They are in line with previous studies in other rodent CIH models, revealing downregulation of mtSOD/SOD2 via downregulation of HIF-2α [48] and clinical observation of lower plasma CuZnSOD/SOD1 in OSA patients [49]. Here, SOD2 is linked to obstructive sleep apnea syndrome.